2024-05-19
2024-02-08
November 21, 2024
Summary | |
---|---|
Cancer Type | Lung Cancer |
Grade | NA |
Stage | NA |
Ethnicity | Asian |
Gender | F |
Age | 69 |
Pathology Diagnosis | Adenocarcinoma, poorly differentiated, malignant cells diffuse infiltrated in lung with massive necrosis. No malignant cells adjacet to stump. Regional LN: hilum of lung LN (3/3), the eleventh group LN (0/2),the fivth group LN (0/1), the seventh group LN (0/3). IHC results: Syn(-), CHgA(+/-), TTF-1(+++), SPB(-), CK7(++), EGFR(-), ER(-), ER-(++), CK20(-), RRM-1(++), CEA(+++), CK34BE12(+), Tubulin b3(+), ERCC-1(++), Ki-67(50%+), CD34(blood vessel +). |
Biopsy Site | primary |
Treatment History | NA |
Pathology QC | Poorly differentiated adenocarcinoma (P3, P6). |
Special Features | NA |
Mouse Strain | Balb/c nu |
TMA | TMA-HP-LU-016 |
Viral Status in PDX | NA |
Available In | CB_CN |
RNA Seq | P4 |
Exome Seq | P1 |
Already Registered? Login
To view this data, close this window and Log In or Register for Access.
© 2024 Crown Bioscience. All Rights Reserved.
© 2024 Crown Bioscience. All Rights Reserved. Privacy Policy